The purpose of this legislation is to improve access to non-opioid pain management medications for Medicare beneficiaries. It aims to provide a safer alternative to opioids for managing pain, thereby addressing the ongoing opioid crisis in the United States. Key provisions of the legislation include changes to how non-opioid pain management drugs are handled under Medicare Part D. Starting January 1, 2026, these drugs will not be subject to deductibles, meaning patients will not have to pay out-of-pocket costs before their insurance kicks in.